0001127602-20-025731.txt : 20200925 0001127602-20-025731.hdr.sgml : 20200925 20200925161910 ACCESSION NUMBER: 0001127602-20-025731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200923 FILED AS OF DATE: 20200925 DATE AS OF CHANGE: 20200925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoge Stephen CENTRAL INDEX KEY: 0001760669 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 201200350 MAIL ADDRESS: STREET 1: C/O MODERNA, INC. STREET 2: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-09-23 0001682852 Moderna, Inc. MRNA 0001760669 Hoge Stephen C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 President Common Stock 2020-09-23 4 M 0 10000 .99 A 1946530 D Common Stock 2020-09-23 4 S 0 3800 66.38 D 1942730 D Common Stock 2020-09-23 4 S 0 8500 67.32 D 1934230 D Common Stock 2020-09-23 4 S 0 2700 68.11 D 1931530 D Common Stock 2020-09-24 4 S 0 1600 64.39 D 1929930 D Common Stock 2020-09-24 4 S 0 2400 65.24 D 1927530 D Common Stock 2020-09-24 4 S 0 1000 66.35 D 1926530 D Common Stock 4116 I By Valhalla, LLC Stock Option (Right to Buy) .99 2020-09-23 4 M 0 10000 0 D 2023-08-19 Common Stock 10000 797431 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.80 to $66.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.81 to $67.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.83 to $68.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.86 to $64.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.89 to $65.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.93 to $66.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. This option is fully vested and exercisable. /s/ Lori Henderson, as Attorney-in-Fact 2020-09-25